Correction: Cilostazol and isosorbide mononitrate for the prevention of progression of : baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850)
===================================================================================================================================================================================================


Bath PM, Mhlanga I, Woodhouse LJ, *et al*. Cilostazol and isosorbide mononitrate for the prevention of progression of : baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) ([ISRCTN14911850](http://svn.bmj.com/external-ref?link_type=ISRCTN&access_num=ISRCTN14911850)). *Stroke Vasc Neurol* 2022;svn-2022-001816. doi: 10.1136/svn-2022-001816

The article was erroneously published without the full title as Cilostazol and isosorbide mononitrate for the prevention of progression of : baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) ([ISRCTN14911850](http://svn.bmj.com/external-ref?link\_type=ISRCTN&access_num=ISRCTN14911850)). This has been amended to Cilostazol and isosorbide mononitrate for the prevention of progression of cerebral small vessel disease: baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) ([ISRCTN14911850](http://svn.bmj.com/external-ref?link_type=ISRCTN&access_num=ISRCTN14911850)). Also, there are LACI 2 Investigators added along with author names in title page. The details of the investigators are added as a supplemental material in the article.

[http://creativecommons.org/licenses/by-nc/4.0/](http://creativecommons.org/licenses/by-nc/4.0/)
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: [http://creativecommons.org/licenses/by-nc/4.0/](http://creativecommons.org/licenses/by-nc/4.0/).